{
  "ticker": "ANIP",
  "company_name": "ANI Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02080091",
      "title": "Observational Study to Assess the Effect of Iluvien\u00ae in DME Patients Insufficiently Responsive to Available Therapies",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Diabetic Macular Edema (DME)",
      "start_date": "2013-12",
      "completion_date": "2015-04",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    },
    {
      "nct_id": "NCT00490815",
      "title": "Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Diabetic Macular Edema",
      "start_date": "2007-08",
      "completion_date": "2011-04",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    },
    {
      "nct_id": "NCT02472366",
      "title": "A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN\u00ae in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Chronic Diabetic Macular Edema",
      "start_date": "2014-01",
      "completion_date": "2015-05",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    },
    {
      "nct_id": "NCT00770770",
      "title": "Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Macular Edema, Retinal Vein Occlusion",
      "start_date": "2009-05",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    },
    {
      "nct_id": "NCT07346079",
      "title": "Purified Cortrophin\u00ae Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares",
      "status": "RECRUITING",
      "phase": "PHASE4",
      "condition": "Gout Arthritis, Gout Flare, Gout",
      "start_date": "2025-12-20",
      "completion_date": "2027-08-31",
      "enrollment": 0,
      "sponsor": "Massachusetts General Hospital"
    },
    {
      "nct_id": "NCT02424019",
      "title": "Phase 4 IOP Signals Associated With ILUVIEN\u00ae",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Diabetic Macular Edema (DME)",
      "start_date": "2015-05-06",
      "completion_date": "2020-07-31",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    },
    {
      "nct_id": "NCT00344968",
      "title": "Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Diabetic Macular Edema",
      "start_date": "2007-09",
      "completion_date": "2010-12",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    },
    {
      "nct_id": "NCT00695318",
      "title": "Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Age-Related Macular Degeneration",
      "start_date": "2008-12",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    },
    {
      "nct_id": "NCT06539481",
      "title": "Open Label Trial Studying the Safety and Effectiveness of ILUVIEN\u00ae (190\u03bcg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.",
      "status": "RECRUITING",
      "phase": "PHASE4",
      "condition": "Non-infectious Uveitis Affecting the Posterior Segment of the Eye",
      "start_date": "2024-08-31",
      "completion_date": "2028-10-31",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    },
    {
      "nct_id": "NCT04469595",
      "title": "A Study of Intravitreal ILUVIEN\u00ae Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE4",
      "condition": "Diabetic Macular Edema",
      "start_date": "2020-08-31",
      "completion_date": "2024-12-31",
      "enrollment": 0,
      "sponsor": "Alimera Sciences"
    }
  ],
  "summary": {
    "total_trials": 14,
    "by_phase": {
      "": 2,
      "PHASE3": 4,
      "PHASE4": 6,
      "PHASE2": 2
    },
    "by_status": {
      "TERMINATED": 3,
      "COMPLETED": 5,
      "RECRUITING": 3,
      "ACTIVE_NOT_RECRUITING": 2,
      "UNKNOWN": 1
    },
    "active_trials": 5,
    "completed_trials": 5,
    "conditions": [
      "Age-Related Macular Degeneration",
      "Chronic Diabetic Macular Edema",
      "Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies",
      "Diabetic Macular Edema",
      "Diabetic Macular Edema (DME)",
      "Gout Arthritis, Gout Flare, Gout",
      "Macular Edema, Retinal Vein Occlusion",
      "Non-infectious Uveitis Affecting the Posterior Segment of the Eye",
      "Uveitis, Posterior",
      "Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:24.009883",
    "search_query": "ANI Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=ANI+Pharmaceuticals,+Inc."
  }
}